Spot Trading’s Medifast MED Stock Holding History

Spot Trading’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-6,300	Closed	-$192K	–	4559
2014 Q2	$192K	Buy	+6,300	New	+$196K	﹤0.01%	3365

Other funds holding MED

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GGPE

Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's MED Position: Q3 2014 in Review

Spot Trading sold out of Medifast (MED) in Q3 2014, closing a stake of 354 shares — an estimated $11K sold.

Spot Trading first reported a position in MED in Q1 2014 and held it in 2 quarters. The position peaked at $74K in Q1 2014. 124 funds tracked by Wall St. Rank hold MED as of Q3 2014.

Spot Trading reported no remaining Medifast position as of Q3 2014 after selling out during the quarter.
Spot Trading sold 354 Medifast shares in Q3 2014, an estimated $11K.
Spot Trading first reported a position in Medifast in Q1 2014 and held it in 2 quarters.
Spot Trading's Medifast position peaked at $74K in Q1 2014.
124 funds tracked by Wall St. Rank held Medifast as of Q3 2014.

Based on Spot Trading's 13F filing for Q3 2014, filed 13 Nov 2014.